Anixa Biosciences Director Lewis H. Titterton Jr acquires $9,172 of common shares

• Anixa Biosciences director Lewis H. Titterton Jr bought 2,797 common shares at USD 3.28 each.
• His direct beneficial ownership rose to 974,967 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033461), on July 16, 2026, and is solely responsible for the information contained therein.